3.8 Article

Disseminated mucormycosis in a patient with severe COVID-19 on venovenous extracorporeal membrane oxygenation: A case report

期刊

IDCASES
卷 29, 期 -, 页码 -

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.idcr.2022.e01578

关键词

Invasive fungal infection; Invasive mucormycosis; Steroid; COVID-19 associated mucormycosis

向作者/读者索取更多资源

This study reported a case of disseminated mucormycosis in a COVID-19 patient during hospitalization. The patient experienced severe respiratory failure, intra-abdominal hemorrhage, and septic shock before death.
Background: Since the global outbreak of coronavirus disease 2019 (COVID-19), there have been several reports of mucormycosis as a secondary complication. However, the disseminated type of mucormycosis is extremely rare.Case: A 58-year-old male patient with COVID-19 started receiving venovenous extracorporeal membrane oxygenation because of severe respiratory failure. During hospitalization, intra-abdominal hemorrhage occurred and an emergency laparotomy was performed. Subsequently, the patient suffered septic shock, and part of the small intestines and the abdominal wall became necrotic. Finally, the patient died. At autopsy, he was diagnosed with disseminated mucormycosis.Conclusion: Disseminated mucormycosis should be considered in patients with COVID-19 with refractory sepsis unresponsive to broad-spectrum antimicrobial therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

3.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据